A series of new 7-piperazinyl and 7-piperidinyl-3,4-dihydroquinazolin-2(1H)-ones has been synthesized. The
described compounds are structurally related to adoprazine, a potential atypical antipsychotic bearing potent D2 receptor
antagonist and 5-HT1A receptor agonist properties. Suitably modified aryl bromides were prepared and condensed with
tert-butyl piperazine-1-carboxylate to afford the advanced intermediate piperazinyl-3,4-dihydroquinazolin-2(1H)-one.
Likewise Suzuki-Miyaura cross-coupling reaction of cyclic vinyl boronate with appropriate aryl bromides rendered
piperidinyl-3,4-dihydroquinazolin-2(1H)-one. The reductive amination of the piperazinyl and piperidinyl-3,4-
dihydroquinazolin-2(1H)-ones with suitably designed biarylaldehydes accomplished the synthesis of these title compounds.
The described compounds were screened for D2 and 5-HT1A receptors binding affinities. The structure-activity relationship
studies revealed that cyclopentenylpyridine and cyclopentenylbenzyl groups contribute significantly to the dual
D2 and 5-HT1A receptor binding affinities of these compounds.
一系列新的7-
哌嗪基和7-
哌啶基-3,4-二氢
喹唑啉-2(1H)-酮已被合成。所述化合物在结构上与阿多拉嗪相关,后者是一种潜在的不典型
抗精神病药物,具有强效的D2受体拮抗剂和5-HT1A受体激动剂特性。制备了适当修饰的芳基
溴化物,并与叔
丁基哌嗪-1-羧酸酯缩合,得到高级中间体
哌嗪基-3,4-二氢
喹唑啉-2(1H)-酮。同样,Suzuki-Miyaura交叉偶联反应中,环状
乙烯基硼酸盐与适当的芳基
溴化物反应,得到
哌啶基-3,4-二氢
喹唑啉-2(1H)-酮。通过
哌嗪基和
哌啶基-3,4-二氢
喹唑啉-2(1H)-酮与适当设计的联芳基醛的还原胺化反应,完成了这些目标化合物的合成。所述化合物被筛选为D2和5-HT1A受体结合亲和力。结构-活性关系研究表明,
环戊烯基
吡啶和
环戊烯基苄基对这些化合物的双重D2和5-HT1A受体结合亲和力有显著贡献。